Low molecular weight heparin prophylaxis in total knee arthroplasty: The answer

Clinical Orthopaedics and Related Research

Volumn 392, Issue , 2001, Pages 245-248

  Colwell Jr , Clifford W ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARDEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; TOTAL KNEE REPLACEMENT;

EID: 0035166796     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200111000-00031     Document Type: Conference Paper

References (18)

1. Prevention of venous thromboembolism
2. Prevention of venous thromboembolism
3. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty
4. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-bline, dose-ranging study
5. Extended out-of-hospital low molecular weight heparin venous thromboembolism prophylaxis after total hip or knee replacement surgery
6. Heparin and low-molecular-heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety
7. Low molecular weight heparin and neuraxial anesthesia
8. Neuraxial block and low molecular weight heparin: Balancing perioperative analgesia and thromboprophylaxis
9. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: A meta-analysis of randomized trials
10. Low molecular weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison
11. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation
12. Prevention of venous thromboembolism after knee arthroplasty: A randomized, double-blind trial comparing enoxaparin with warfarin
13. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: A multi-institutional cohort study of patients who underwent hip or knee arthroplasty
14. Low molecular weight heparin in prevention of pulmonary embolic thrombosis
15. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty
16. Enoxaparin, a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery
17. Deep-vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties
18. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty